Co-Authors
This is a "connection" page, showing publications co-authored by Michel Drancourt and Jean-Christophe Lagier.
Connection Strength
1.455
-
Rapid Isothermal Amplification for the Buccal Detection SARS-CoV-2 in the Context of Out-Patient COVID-19 Screening. J Clin Med. 2021 Jun 16; 10(12).
Score: 0.238
-
SARS-CoV-2 Persistent Viral Shedding in the Context of Hydroxychloroquine-Azithromycin Treatment. Viruses. 2021 05 12; 13(5).
Score: 0.236
-
Evaluating the serological status of COVID-19 patients using an indirect immunofluorescent assay, France. Eur J Clin Microbiol Infect Dis. 2021 Feb; 40(2):361-371.
Score: 0.228
-
Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis. Travel Med Infect Dis. 2020 Jul - Aug; 36:101791.
Score: 0.222
-
Naming microorganisms: the contribution of the IHU Méditerranée Infection, Marseille, France. New Microbes New Infect. 2018 Nov; 26:S89-S95.
Score: 0.195
-
Many More Microbes in Humans: Enlarging the Microbiome Repertoire. Clin Infect Dis. 2017 Aug 15; 65(suppl_1):S20-S29.
Score: 0.182
-
Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France. Travel Med Infect Dis. 2020 May - Jun; 35:101738.
Score: 0.055
-
Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study. Travel Med Infect Dis. 2020 Mar - Apr; 34:101663.
Score: 0.055
-
Staphylococcus lugdunensis: An Underreported Pathogen in Osteomyelitis. J Foot Ankle Surg. 2017 Mar - Apr; 56(2):412-413.
Score: 0.044